Highlights and Quick Summary
- Annual 3Y Revenue Growth (per Share) for 2022 was -4.82% (a -110.82% decrease from previous year)
- Annual 3Y Revenue Growth (per Share) for 2021 was 44.56% (a -57.37% decrease from previous year)
- Annual 3Y Revenue Growth (per Share) for 2020 was 104.53% (a 38.56% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Revenue Growth (per Share) of Organigram Holdings Inc.
Most recent 3Y Revenue Growth (per Share)of OGI including historical data for past 10 years.Interactive Chart of 3Y Revenue Growth (per Share) of Organigram Holdings Inc.
Organigram Holdings Inc. 3Y Revenue Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -4.82% |
| 2021 | – | – | – | – | 44.56% |
| 2020 | – | – | – | – | 104.53% |
| 2019 | – | – | – | – | 75.44% |
| 2018 | – | – | – | – | -31.37% |
| 2017 | – | – | – | – | -51.53% |
| 2016 | – | – | – | – | -42.94% |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic